4//SEC Filing
Klichinsky Michael 4
Accession 0001104659-25-097928
CIK 0001485003other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 4:16 PM ET
Size
9.1 KB
Accession
0001104659-25-097928
Insider Transaction Report
Form 4
Klichinsky Michael
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-07$0.11/sh+56,982$6,268→ 56,982 total - Exercise/Conversion
Stock Option (right to buy)
2025-10-07−56,982→ 0 totalExercise: $0.11Exp: 2027-11-01→ Common Stock (56,982 underlying) - Sale
Common Stock
2025-10-07$0.25/sh−56,982$14,485→ 0 total
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2441 to $0.2647, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F2]The option was fully vested.
Documents
Issuer
Carisma Therapeutics Inc.
CIK 0001485003
Entity typeother
Related Parties
1- filerCIK 0001967221
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 4:16 PM ET
- Size
- 9.1 KB